Distribution of glutamate and preproenkephalin messenger RNAs following transient focal cerebral ischemia

Neuroscience

Volumn 95, Issue 3, 1999, Pages 841-857

  Friedman, L K ^a,b   Belayev, L ^c   Alfonso, O F ^c   Ginsberg, M D ^c  

^a Seton Hall Univ/NJ Neurosci I ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Caudate putamen; Focal ischemia; Glutamate receptors; Neocortex; Neurodegeneration; Opioids

Indexed keywords

GLUTAMIC ACID; MESSENGER RNA; PREPROENKEPHALIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; CELL LABELING; CINGULATE GYRUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CEREBRAL INFARCTION; CORPUS STRIATUM; DOWN-REGULATION; ENKEPHALINS; GLUTAMIC ACID; ISCHEMIC ATTACK, TRANSIENT; MALE; NEOCORTEX; NERVE DEGENERATION; NEURONS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0032804101     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00452-2     Document Type: Article

References (90)

1. Beckstead R.M. N-Methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse. 21:1995;342-347.
2. Belayev L., Busto R., Zhao W., Ginsberg M.D. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke. 26:1995;2313-2320.
3. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
4. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3:1991;213-245.
5. Bessho Y., Nawa H., Nakanishi S. Selective upregualtion of an NMDA receptor subunit mRNA in cultured cerebellar granule cells by K(+)-induced depolarization and NMDA treatment. Neuron. 12:1994;87-95.
6. Bettler B., Mulle C. Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology. 34:1995;123-139.
7. Buchan A., Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist MK-801 attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10:1990;311-316.
8. Buchan A., Li H., Pulsinelli W.A. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci. 11:1991;1049-1056.
9. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
10. Butcher S.P., Bullock R., Graham D.I., McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21:1990;1727-1733.
11. Charriaut-Marlangue C., Aggoun-Zouaoui D., Repressa A., Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy, and gp 120 toxicity. Trends Neurosci. 19:1996;109-114.
12. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
13. Condorelli D.F., Bellueardo G., Mudo G., Dell P., Jiang G.-S. Changes in gene expession of AMPA-selective glutamate receptor subunits induced by status epilepticus in rat brain. Neurochem. Int. 25:1994;367-376.
14. Crépel V., Hammond C., Chinestra P., Diabira D., Ben-Ari Y. A selective LTP of NMDA receptor-mediated currents induced by anoxia in CA1 hippocampal neurons. J. Neurophysiol. 70:1993;2045-2055.
15. Frank L., Diemer N.H., Kaiser F., Sheardown M., Rasmussen J.S., Kristenstein P. Unchanged balance between levels of mRNA encoding AMPA encoding AMPA glutamate receptor subtypes following global cerebral ischemia in the rat. Acta neurol. scand. 92:1995;337-343.
16. Franklin J.L., Johnson E.M. Jr. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15:1992;501-508.
17. Franklin J.L., Johnson E.M. Jr. Elevated intracellular calcium blocks programmed cell death. Ann. N. Y. Acad. Sci. 747:1994;195-204.
18. 2+ influx but not Trk activation. J. Neurosci. 15:1995;643-664.
19. A receptor gene expression in adult rat hippocampus: an in situ hybridization study. J. Neurosci. 14:1994;2697-2707.
20. Friedman L. K., Ginsberg M. D., Alfonso O. F. and Globus M. (1998) Effects of intraischemic hypothermia on AMPA and NMDA receptor gene expression following transient global Ischemia in the rat. The Third International Workshop on Maturation Phenomenon in Cerebral Ischemia: Defensive Mechanisms versus Apoptosis. The Neuromed Institute, Pozzilli.
21. Friedman L.K. Selective reduction of GluR2 protein in adult hippocampal CA3 neurons following status epilepticus but prior to cell loss. Hippocampus. 8:1998;511-525.
22. Friedman L.K., Velísková J. GluR2 hippocampal knockdown reveals developmental regulation of epileptogenicity and neurodegeneration. Molec. Brain Res. 61:1998;224-231.
23. Gallyas F., Wolff J.R., Bàttcher W.H., Zaborszky L. A reliable and sensitive method to localize terminal degeneration and lysozomes in the central nervous system. Stain Technol. 55:1980;299-306.
24. Gao T.M., Pulsinelli W.A., Xu Z.C. Prolonged enhancement and depression of synaptic transmission in CA1 pyramidal neurons induced by transient forebrain ischemia in vivo. Neuroscience. 87:1998;371-383.
25. 2+ permeability of AMPA receptors in principal neurons and interneurons. Neuron. 15:1995;193-204.
26. Gill R. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 6:1994;225-256.
27. Gill R., Nordhom L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580:1992;35-43.
28. Ginsberg M. D. (1995) Neuroprotection in brain ischemia - an update. Parts I and II. Neuroscientist 1, 95-103, 164-175.
29. Globus M.Y.T., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
30. Globus M.Y.T., Busto R., Martinez E., Valdes I., Dietrich W.D., Ginsberg M.D. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J. Neurochem. 57:1991;470-478.
31. Gottlieb M., Matute C. Changes in the expression of ionotropic glutamate receptor subunits in the hippocampal CA1 area following transient forebrain ischemia. J. cerebr. Blood Flow Metab. 17:1997;290-300.
32. Haber S.N., Lu W. Distribution of preproenkephalin messenger RNA in the basal ganglia and limbic-associated regions of the monkey telencephalon. Neuroscience. 65:1995;417-429.
33. Hammond C., Crépel V., Gozlan H., Ben-Ari Y. Anoxic LTP sheds light on the multiple facets of NMDA receptors. Trends Neurosci. 17:1994;497-503.
34. Harlan R.E., Shivers B.D., Romano G.J., Howells R.D., Pfaff D.W. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J. comp. Neurol. 258:1987;159-184.
35. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 253:1991;1028-1031.
36. Hong S.C., Lanzino G., Yasunobu G., Kang G.S., Schottler F., Kassell N.F., Lee K.S. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res. 661:1994;43-50.
37. Hori Y., Katsuaki E., Takahashi T. Presynaptic inhibitory action of enkephalin excitatory transmission in superficial dorsal horn of rat spinal cord. J. Physiol. 450:1992;673-685.
38. Hossmann K.A. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Path. 4:1994;23-36.
39. Hossmann K.A. Periinfarct depolarizations. Cerebrovasc. Brain Metab. Rev. 8:1996;195-208.
40. Jiang Z.G., North R.A. Pre- and postsynaptic inhibition by opioids in rat striatum. J. Neurosci. 12:1992;356-361.
41. Kadotani H., Namura S., Katsuura G., Terashima T., Kikuchi H. Attenuation of focal cerebral infarct in mice lacking NMDA receptor subunit NR2C. NeuroReport. 9:1998;471-475.
42. Keinänen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakmann B., Seeburg P.H. A family of AMPA-selective glutamate receptors. Science. 249:1990;556-560.
43. 2+ permeable AMPA and NMDA receptor channels in basket cells of rat hippocampal dentate gyrus. J. Physiol. 455:1995;383-402.
44. Kraus J.E., Yeh G.C., Bonhaus D.W., Nadler J.V., McNamara J.O. Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3. J. Neurosci. 14:1994;196-205.
45. Kristian T., Gido G., Kuroda S., Schwartz A., Siesjö B.K. Calcium metabolism of focal and penumbral tissues in rats subjected to transient middle cerebral artery occlusion. Brain Res. 120:1998;503-509.
46. 2+ influx. J. Neurobiol. 26:1995;205-212.
47. Li H., Buchan A.M. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. cerebr. Blood Flow Metab. 13:1993;933-939.
48. Luthmann H., Mudrick-Donnon L.A., Mittmann T., Heinemann U. Ischemia-induced long-term hyperexcitability in rat neocortex. Eur. J. Neurosci. 7:1995;180-191.
49. Mies G., Kohno K., Hossmann K.A. Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J. cerebr. Blood Flow Metab. 14:1994;802-807.
50. Nakanishi N., Axel R., Schneider N.A. Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. natn. Acad. Sci. U.S.A. 89:1992;8552-8556.
51. Nilsson P., Laursen H., Hillered L., Hansen A.J. Calcium movements in traumatic brain injury: role of glutatmate receptor-operated ion channels. J. cerebr. Blood Flow Metab. 16:1996;262-270.
52. Nomura K., Reuveny E., Narahashi T. Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J. Pharmac. exp. Ther. 270:1994;466-474.
53. North R. A. (1993) Opioid actions on membrane ion channels. In Handbook of Experimental Pharmacology (eds Hertz A., Akil H. and Simon E. J.), pp. 773-797. Springer, Berlin.
54. Ozyurt E., Graham D.I., Woodruff G.N., McCulloch J. Protective effect of the glutamate antagonist MK-801 in focal cerebral ischemia in the cat. J. cerebr. Blood Flow Metab. 8:1988;138-143.
55. Park C.K., Nehls D.G., Graham D.I., Teasdale G.M., McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24:1988;543-551.
56. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, Sydney.
57. Pellegrini-Giampietro D.E., Zukin R.S., Bennett M.V.L., Cho S., Pulsinelli W.A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. natn. Acad. Sci. U.S.A. 89:1992;10,499-10,503.
58. Pellegrini-Giampietro D.E., Pulsinelli W.A., Zukin R.S. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists. J. Neurochem. 62:1994;1067-1073.
59. Pollard H., Moreau H.J., Ben-Ari Y., Khrestchatisky M. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience. 57:1993;545-554.
60. Popovici T., Margaill I., Plotkine M., Ben-Ari Y., Charriaut-Marlangue C. Down-regulation of striatal enkephalinergic (PPA) messenger RNA without prior apoptotic features following reversible focal ischemia in the rat. Brain Res. 744:1997;185-187.
61. Pulsinelli W. Pathophysiology of acute ischaemic stroke. Lancet. 339:1992;533-536.
62. Pulsinelli W., Sarokin A., Buchan A. Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Prog. Brain Res. 96:1993;125-135.
63. Rogard M., Caboche J., Julien J.F., Besson M.J. The rat nucleus accumbens: two levels of complexity in the distribution of glutamic acid decarboxylase (67 kDa) and preproenkephalin messenger RNA. Neurosci. Lett. 155:1993;81-86.
64. Rosen H., Douglass J., Herbert E. Isolation and characterization of the rat proenkephalin gene. J. biol. Chem. 259:1984;14,309-14,313.
65. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
66. Ruzicka B.B., Jhamandas K. Elevation of met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following focal injection of excitotoxins. Brain Res. 536:1990;227-239.
67. Sheardown M.J., Suzdak P.D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmac. 236:1993;347-353.
68. Siesjö B.K., Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-mediated pathology in brain ischemia, hypoglycemia, and spreading depression. J. cerebr. Blood Flow Metab. 9:1989;127-140.
69. Siesjö B.K., Zhao Q., Pahlmark K., Siesjö P., Katsura K., Folbergrov J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. thorac. Surg. 59:1995;1316-1320.
70. Simon R., Shiraishi K. N-Methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann. Neurol. 27:1990;606-611.
71. Smith S.E., Meldrum B.S. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke. 23:1992;861-864.
72. Somers D.L., Beckstead R.M. Striatal pretachykinin and preproenkephalin mRNA levels and levels of nigral substance P and pallidal met-enkephalin depend on corticostriate axons that use the excitatory amino acid glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence. Brain Res. molec. Brain Res. 8:1990;143-158.
73. Somers D.L., Beckstead R.M. N-Methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmac. exp. Ther. 262:1992;823-833.
74. Sommer B., Keinänen K., Verdoon T.A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., Seeburg P.H. Flip and flop: a cell specific functional switch in operated channels of the CNS. Science. 249:1990;1580-1585.
75. Takagi K., Ginsberg M.D., Globus M.Y.T., Dietrich W.D., Martinez E., Kraydieh S., Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J. cerebr. Blood Flow Metab. 13:1993;575-585.
76. Toth Z., Hollrigel G.S., Gorcs T., Soltesz I. Instantaneous perturbation of dentate interneuronal networks by pressure wave-transient delivered to the neocortex. J. Neurosci. 17:1997;8106-8117.
77. Tymianski M. (1998) The central role of calcium ions and calcium-permeable channels in ischemic brain injury. In Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management (eds Ginsberg M. D. and Bogousslavsky J.), pp. 371-390. Blackwell Science, Malden, MA.
78. Ueda M. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neuropharmacology. 34:1995;303-308.
79. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252:1991;1715-1718.
80. Vornov J.J. Toxic NMDA-receptor activation occurs during recovery in a tissue culture model of ischemia. J. Neurochem. 65:1995;1681-1691.
81. Wahlestedt C., Golanov E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturrisi C.E., Reis D.J. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature. 363:1993;260-263.
82. Warner M.A., Neill K.H., Nadler J.V., Crain B. Regionally selective effects of NMDA receptor antangonists against ischemic brain damage in the gerbil. J. cerebr. Blood Flow Metab. 11:1991;600-610.
83. Washburn M.S., Numberger M., Zhang S., Dingledine R. Differential dependence in GluR2 expression characteristic features of AMPA receptors. J. Neurosci. 17:1997;9393-9406.
84. Westbrook G.L. Glutamate receptor update. Curr. Opin. Neurobiol. 4:1994;333-346.
85. Xue D., Huang Z.G., Barnes K., Lesiuk H.J., Smith K.E., Buchan A.M. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. cerebr. Blood Flow Metab. 4:1994;251-261.
86. Yang H.Y.T., Hong J.S., Costa E. Regional distribution of Leu- and Met-enkephalin in rat brain. Neuropharmacology. 16:1977;303-307.
87. Yoshikawa K., Williams C., Sabol L.S. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. biol. Chem. 259:1984;14,301-14,308.
88. Young J.N., Somjen G.G. Suppression of presynaptic calcium currents by hypoxia in hippocampal tissue slices. Brain Res. 573:1992;70-76.
89. Zea Longa E.L., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
90. Zhang F., Bree V., Albala N., Verslype M., Vanderhaegen J.J. NMDA receptor anatagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs. Neurochem. Int. 28:1995;189-192.